That’s why more conservative treatments may not produce the results you want — they don’t target the miscommunication between your bowel and brain. Medtronic Bowel Control Therapy delivered by the InterStim™ system is thought to correct the bowel-brain communication pathway to help control the symptoms of chronic FI.
Implanting an InterStim system has risks similar to any surgical procedure, including swelling, bruising, bleeding, and infection. Talk with your doctor about ways to minimize these risks.
Quarter shown for size comparison
The most common adverse events were: implant site pain, paresthesia, change in sensation of stimulation, implant site infection, urinary incontinence, neurostimulator battery depletion, diarrhea, pain in extremity, undesirable change in stimulation, and buttock pain.
You may be a good candidate for Medtronic Bowel Control Therapy delivered by the InterStim system if:
Unlike other bowel control treatments, our therapy lets you try it first. It’s called an evaluation — like a test run, not a long-term commitment.
Complications can occur with the evaluation, including movement of the wire, technical problems with the device, and some temporary pain. Your doctor or nurse will show you how to use the system, and inform you of any activity restrictions and other precautions related to the evaluation.
Success defined as ≥ 50% reduction of episodes/week. This patient group had data at both baseline and the 5 year visit. Another analysis reported 69% of people achieved success with Medtronic Bowel Control Therapy. For this patient group, missing data at 5 years because of a device-related reason was counted as failure or if it was missing for non-device related reasons, the most recent data was carried forward.
Hull T, Giese C, Wexner SD, et al. Long-term Durability of Sacral Nerve Stimulation Therapy for Chronic Fecal Incontinence. Dis Colon Rectum. 2013; 56(2):234-45.
Tjandra JJ, Chan MKY, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum. 2008;51(5):494-502.